Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from NVO

Dow Jones Futures Fall: Market Rally Looks Great, But Beware This; 8 Stocks Near Buy Points

The market rally continues its strong November run, but a key fear gauge raises some concerns. Weight-loss drug giant Novo Nordisk broke out Friday, leading stocks to watch.

Investors Business Daily

3 Buy-Rated Healthcare Dividend Stocks for Income Investors

3 Buy-Rated Healthcare Dividend Stocks for Income Investors

Looking for analysts' favorite stock picks in a traditionally defensive sector, with solid dividend payments to help boost your returns? Here's a look at three stocks for income investors to consider at current levels.

GE, Amazon Lead 5 Stocks Near Buy Points With This Bullish Trait

GE, Amazon Lead 5 Stocks Near Buy Points With This Bullish Trait

Relative strength is key when choosing top stocks. GE stock and Amazon stock pass the RS Line Blue Dot screen.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Dow Jones Futures Rise, 3 Big Movers; Elon Musk's 'Actual Truth' Hits Tesla

The S&P 500 edged higher Thursday despite earnings losers. Leading stocks were resilient. Tesla fell after Elon Musk's 'actual truth' post.

Investors Business Daily

3 Top-Rated Pharma Stocks Worth Including in Your November Portfolio

The pharmaceutical sector is booming with increasing global healthcare demands and technological progress. Hence, top-rated pharma stocks Dr. Reddy’s (RDY), Novo Nordisk (NVO), and AbbVie (ABBV) might be solid additions to one’s portfolio in November. Read more.

3 'Strong Buy' Dividend Stocks That Are Beating the Market

Here are three top-rated dividend stocks that have outperformed the S&P 500 in the past month, despite a tough environment for equities.

NVO Stock Ended Up Being Healthy For Swing Trading Portfolios

Rather than holding out for big gains in a tough market, our selling into strength made this stock a winner.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

3 Pharma Stocks With Market Impact to Consider Buying

3 Pharma Stocks With Market Impact to Consider Buying

The pharmaceutical sector is expected to thrive due to the rising demand for advanced medicines to treat lifestyle diseases and its increasing ability to meet quality treatment needs thanks to technological advancements. Therefore, it could be wise to add fundamentally strong pharma stocks Amneal Pharmaceuticals (AMRX), Dr. Reddy’s Laboratories (RDY),…

3 Top-Rated Growth Stocks To Buy on Every Dip

3 Top-Rated Growth Stocks To Buy on Every Dip

Growth stocks are down, but don't count them out. Here are three top-rated names worth scooping up when the market pulls back.

Dow Jones Futures Rise After Market Rally Hits Resistance; Tesla, Nvidia Lead New Buys

Dow Jones Futures Rise After Market Rally Hits Resistance; Tesla, Nvidia Lead New Buys

The stock market rally continued to advance, but the Nasdaq hit key resistance. Tesla and Nvidia offered new entries.

Investors Business Daily

3 A-Rated Pharma Buys for October

3 A-Rated Pharma Buys for October

The growing adoption of innovative drugs and the heightened demand for personalized medicines are expected to boost the pharma industry. Therefore, it might be wise to buy fundamentally strong pharma stocks Neurocrine Biosciences (NBIX), Novo Nordisk (NVO), and AstraZeneca PLC (AZN), which are rated an A (Strong Buy) in our…

3 Biotechs with Massive Growth Potential

3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records of finding ways to introduce products into those markets to capture big profits.…

3 A-Rated Pharma Stocks to Buy Today

3 A-Rated Pharma Stocks to Buy Today

The pharmaceutical industry is expected to grow in the upcoming years, propelled by continual advancements in medicine, aiming to meet the escalating demands for chronic disease treatment and address the needs of an aging population. Therefore, quality pharma stocks Neurocrine Biosciences (NBIX), AbbVie Inc. (ABBV), and Novo Nordisk A/S (NVO),…

Top 3 Pharma Stocks to Boost Your Portfolio

Top 3 Pharma Stocks to Boost Your Portfolio

As the global population ages and faces the increasing toll of chronic diseases, the pharmaceutical industry is expected to step up to meet people’s healthcare needs. Against this backdrop, pharma companies like Novo Nordisk (NVO), AbbVie (ABBV), and Novartis (NVS) could boost your portfolio. Read on….

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Rise After Nasdaq, Nvidia Break Support In AI Sell-Off; Inflation Data Due

The Nasdaq and Nvidia fell below their 50-day moving averages, with AI stocks tumbling. Inflation data is on tap. Here's what to do now.

3 Pharma Stock Buys You Don’t Want to Miss

The pharmaceutical industry is growing amid robust demand. Also, given that healthcare stocks are generally thought of as defensive investments, fundamentally strong Johnson & Johnson (JNJ), Novo Nordisk (NVO), and AstraZeneca (AZN) might be profitable buys now. Read on.

Investors Business Daily

AI Stocks Lead These 5 Names Near Buy Points

Artificial intelligence stocks including chipmaker Marvell Technology (MRVL), Arista Networks (ANET) and Synopsys (SNPS), which has launched AI-based chip-design tools, lead this weekend's watch list of five stocks near buy points. In addition to MRVL, ANET and SNPS stock, weight-loss drug leader Novo Nordisk (NVO) and Heico (HEI), a military…

Investors Business Daily

Novo Nordisk Stock Today: This Diagonal Calendar Spread Trade Has Limited Risk, Unlimited Profit Potential

Concerns of weight loss and Type 1 diabetes are fueling the rise of our choice for this week's option position in shares of Novo Nordisk.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures: Tesla Tumbles In Divided Market, But This Was The Key Loser

Tesla and Netflix were big losers in a deeply divided market Thursday, but this chip giant was the most important.

3 July Pharma Picks for Profit

The pharma industry performs relatively well during downturns due to inelastic demand for its products and services. Therefore, fundamentally strong pharma stocks Novo Nordisk (NVO), AbbVie (ABBV), and Novartis (NVS) might be profitable buys. Read on.

Diabetes Epidemic Makes this Stock a Strong Buy

Diabetes is a growing concern as more of the globe becomes modernized and with that is eating a diet that too often is a road to diabetes. Gladly there are drug companies at the forefront of this movement to stem the tide like Novo Nordisk (NVO) making it a very…

Tilray Brands (TLRY) vs. Novo Nordisk (NVO): Which Pharma Stock Should You Buy?

The pharmaceutical sector performs relatively well during economic uncertainties due to inelastic demand for its products and services. While prominent players Tilray Brands (TLRY) and Novo Nordisk (NVO) should benefit, which stock is the better buy now? Read more to find out.

Why You Should Go Overweight On Novo Nordisk Stock

Novo Nordisk is already the global kingpin in diabetes treatments, with about 30% of the $50+ billion global diabetes market and around half of the $20 billion insulin therapy market. Now, it is becoming a powerhouse in weight-loss drugs, thanks to its Wegovy drug.

3 Pharmaceutical Stocks to Watch

The pharmaceutical industry is anticipated to grow due to rising chronic diseases and an aging population. Given the industry's strong long-term prospects, quality stocks Novo Nordisk (NVO), Novartis (NVS), and Bristol-Myers Squibb (BMY) could be worth adding to your watchlist. Continue reading….

3 Value Stocks to Add to Your Portfolio

The stock market will likely remain under pressure with rising concerns about an economic slump and high-interest rates. Therefore, investors could look to add fundamentally strong stocks Novo Nordisk (NVO), Novartis (NVS), and NetScout Systems (NTCT) to their portfolios, which are trading at discounts. Keep reading….

1 2 3 4

People

Kritika SarmahHer

Steve Reitmeister

Steven AdamsAfter

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

236,456 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play